Johnson & Johnson deserves more credit for another healthy quarter and strong guidance

The new year has been tough for pharma stocks, including JNJ. But it should not be read as an indictment of the company’s practices.


News of max: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Back to top button